



AFRICAN JOURNAL OF CLINICAL AND EXPERIMENTAL MICROBIOLOGY       MAY 2012             ISBN 1595-689X    VOL 13(2) 
AJCEM/201179/21203                              -http://www.ajol.info/journals/ajcem 
COPYRIGHT 2012 
AFR. J. CLN. EXPER. MICROBIOL 13(2): 106-111 http://dx.doi.org/10.4314/ajcem.v13i2.9 
 
CAMPYLOBACTER SPP. EPIDEMIOLOGY AND ANTIMICROBIAL SUSCEPTIBILITY IN A DEVELOPING 
COUNTRY, BURKINA FASO (WEST AFRICA) 
 
L. Sangaré1,2,*, A.K. Nikiéma2, S. Zimmermann3, I. Sanou1,2, M. Congo-Ouédraogo1,  A. Diabaté1, S. Diandé4, P.I. 
Guissou2,5. 
 
1 Service de Bactériologie-Virologie, CHU Yalgado Ouédraogo, 03 BP 7022 Ouagadougou 03, Burkina Faso ; 2 Unité de 
Formation et de Recherche en Sciences de la Santé, Université de Ouagadougou, 03 BP 7021 Ouagadougou 03, Burkina 
Faso ; 3 Department of Infectious Diseases, Medical Microbiology and Hygiene, Im Neuenheimer Feld 324 D-69120 
Heidelberg, Germany; 4 Service de la Pharmacie Hospitalière, CHU Yalgado Ouédraogo, 03 BP 7022 Ouagadougou 03, 
Burkina Faso 
 
RUNNING TITLE: CAMPYLOBACTER IN BURKINA FASO 
 
*CORRESPONDENCE: Dr Lassana Sangaré, Service de Bactériologie-Virologie, CHU Yalgado Ouédraogo, 03 BP 7022 
Ouagadougou 03, Burkina Faso. Tel.: +226 50311656/57 p 425; Fax: +226 50311848. E-mail: sangarel@hotmail.com 
 
ABSTRACT 
Data on campylobacteriosis are almost nonexistent in Burkina Faso. In this study conducted from 2006 to 2008 in 
Ouagadougou, stool specimens and sociodemographic data were collected from 1 246 patients attending the university 
teaching hospital for enteritis. Stool samples were analyzed for the presence of Campylobacter by the direct culture 
method on selective mCCDA agar followed by antibiotic susceptibility testing on the isolated strains. The isolation 
rate of Campylobacter was 2.3%,comprising of the following species C. jejuni (51.8%), C. coli (13.8%), and C. 
upsaliensis (3.5%). However, 30.9% of the isolates were unidentified. No resistant strain was found to gentamicin. The 
resistance to amoxicillin+clavulanic acid (3.4%) was lower than those (10.3-34.5%) to the other antibiotics: 
erythromycin (10.3%), tetracycline (10.3%), ciprofloxacin (13.8%), amoxicillin (24.1%) and ceftriaxone (34.5%), nalidixic 
acid (34.5%). Significant associations were found between Campylobacter enteritis and contact with animals (P=0.03), 
and HIV infection (P<0.0001), in contrast   to other sociodemographic and seasonal factors. From the data obtained   
Amoxicillin+clavulanic acid appear to be the first choice for treatment. The implementation of a national program 
may be helpful in controlling the spread of the disease and the increase of resistance to antibiotics. 
Keywords: Campylobacter, epidemiology, HIV, drug resistance, Burkina Faso.  
 
INTRODUCTION 
Campylobacter gastroenteritis have a major public 
health importance worldwide, and their rate has 
been increasing (1, 2). Campylobacter is the most 
common cause of culture proven bacterial 
gastroenteritis in developed and developing 
countries, responsible for 400-500 million cases of 
diarrhea each year (3). However, the clinical, 
laboratory and epidemiological data available are 
mostly from developed countries (1, 2, 4, 5). In these 
countries, the highest rates are found among 
children less than five years old and young adults, 
mostly men aged from 20 to 29. In developing 
countries where studies have been conducted, the 
data showed that Campylobacter enteritis is 
particularly associated with young children (1, 2). 
These last years, the diarrhea mortality has declined 
in the world due to increased use of therapies, 
improved nutrition feeding, hygiene and sanitation. 
More recent data showed that the rates of 
campylobac-teriosis have been decreasing in 
numerous developing countries (3, 6, 7, 8).   
Campylobacter infection is a zoonotic disease that can 
be hyper endemic, linked to outbreaks and sporadic 
infections. Known risk factors for the disease 
include ingestion of undercooked poultry and other 
meat, contaminated food and water or 
unpasteurized milk and dairy products, direct 
contact with pets, farm animals, small children, and 
swimming in lakes, but also travel abroad. Direct  
 
 
person-to-person transmission between adults 
appears to be uncommon. In some developed 
countries, seasonal patterns in pets and in human 
infections as well as travel-related infections have 
been observed (2, 4, 9, 10, 11). Several hypotheses 
have been advocated to explain the seasonality of 
Campylobacter infections, including the controversial 
role of flies as vectors (12, 13); however much 
remains to be done about the epidemiology of these 
pathogens. Clinically, the disease is often more 
severe and longer in developed countries, with 
bloody stools, than cases in developing countries 
where it is shorter and stools are more liquid and 
can contain leukocytes (1, 13). Campylobacter 
enteritis can be asymptomatic and self-limiting; in 
severe cases effective antibiotic therapies are 
available. However, acquired resistance to 
macrolides, fluoroquinolones and other antibiotics 
used most widely gives rise to a challenge in 
campylobacteriosis control worldwide (3, 14, 15, 16). 
Data on campylobacteriosis in developing countries 
including most of the sub-Saharan Africa are few (1, 
17, 18, 19). In Burkina Faso, no data of autochthon 
cases are available for animals, foods, environment 
or humans. The only scientific report related to 
Campylobacter enteritis acquired in Burkina Faso is 
about cases from Belgian (8) and Swedish (9) 
international travellers who had stayed in the 




The aim of this study was to present bacteriological 
and epidemiological data on Campylobacter enteritis 
among autochthon patients with diarrhea in 
Burkina Faso. 
 
MATERIALS AND METHODS 
Patients and Sample collection 
A series of 1246 consecutive specimens of stool were 
obtained from patients attending clinics at the 
University Hospital CHUO for acute gastroenteritis, 
between November 2006 and February 2008. No 
patient received antibiotic therapy up to 72h prior to 
the sample collection which was carried out using 
sterile flasks. Sociodemographic data and 
macroscopic aspects of stool specimens were 
recorded using a structured questionnaire. The 
informed consent of each patient and the approval 
of the institution ethical committee had been 
obtained. All stool specimens were collected at the 
University Hospital and were analysed within 1h 
after arrival. 
 
Bacteriological investigations and drug 
susceptibility testing 
The presence of leukocytes and erythrocytes in 
stools was determined microscopically. For 
Campylobacter isolation, each sample was streaked 
onto a modified charcoal cefoperazone 
desoxycholate agar, mCCDA (Oxoid, United 
Kingdom). The CCDA comprised of Campylobacter 
blood-free selective agar base with Campylobacter 
selective supplement (Oxoid) and Campylobacter 
growth supplement (Oxoid). The plates were 
incubated for 48 h at 37°C under microaerophilic 
conditions (5% O2, 5% CO2, 2% H2, and 88% N2 by 
volume) generated by Campy pack plus (Becton 
Dickinson) or GENbox Microaer (bioMérieux SA; 
France). Colonies resembling those of Campylobacter 
(gray, flat, and spreading) were further evaluated 
by Gram’s stain, oxidase and catalase activities, and 
by growth on duplicate plates of Columbia Blood 
Agar with 5% (v/v) defibrinated horse blood 
(bioMerieux SA). The two plates were incubated at 
37°C for 48h, under different conditions: one 
aerobically and one under microaerophilic 
conditions. Oxidase- and catalase-positive colonies 
exhibiting a characteristic Gram stain appearance 
(Gram-negative S-shaped rods) and growing only 
under microaerophilic conditions were reported to 
identify the genus of Campylobacter. Suspensions of 
these colonies to a turbidity equivalent to 6 
McFarland were inoculated to API Campy gallery 
system (bioMérieux) to differentiate the 
Campylobacter strains into species. 
Drug susceptibility tests of the isolates were 
conducted by disc diffusion method: all laboratory-
confirmed Campylobacter isolates were inoculated 
onto Mueller-Hinton agar plates supplemented with 
5% sheep’s blood (bioMérieux) and incubated at 
37°C for 24h. Amoxicillin (25µg), 
amoxillin/clavulanic acid (10µg), ceftriaxone (30µg), 
gentamicin (10µg), erythromycin (15µg), tetracycline 
(30µg), nalidixic acid (30µg) and ciprofloxacin (5µg) 
disks (bioMérieux) were tested. The disc diffusion 
method was used, according to the guidelines of the 
French Society for Microbiology (20). In this study 
any strain with an intermediate sensitivity was 
considered resistant. C jejuni ATCC 25936 and C. coli 
ATCC 33559 strains were used as controls 
throughout the testing period. 
 
Statistical analysis 
The Epi-Info 3.3.2 version 2004 software was used to 
record all data. Comparisons between qualitative 
variables were done using the Chi-2 test (Likelihood 
Ratio or Linear-by-Linear Association or Mantel-
Haenszel method). Statistical significance between 
differences was set at P<0.05. 
 
RESULTS 
Patient characteristics  
Among the 1246 patients, 638 (51.2%) were male. 
Their mean age was 21 years [ranges: 0-80years]; the 
most important age ranges were 0-5 years (n=494; 
39.7%), 21-25 years (n=174; 11.9%) and 26-30 years 
(n=158; 10.9%). Patients living in Ouagadougou 
(n=1188; 95.3%) were more represented than those 
coming from other urban and rural areas (n=58; 
4.7%). More than half (n=670; 53.8%) of overall 
patients were educated and those hospitalized 
(n=640; 51.4%) were more represented than 
outpatients (n=606; 48.6%). Seven (0.6%) patients 
were HIV-1 positive.  
Macroscopic aspects of stool specimens and faecal 
leukocytes 
Four types of stools were reported: pasty (65%), 
liquid (18.9%), mucous (11.1%) and formed (5%). 
Pasty stool specimens were more frequent than 
other types. Leukocytes were found in 164 (13.2%) 
fresh stool specimens after microscopic 
examination.    
 
Bacteriological data 
In this study in Burkina Faso, the isolation rate of 
Campylobacter was 2.3% (29/1246). C. jejuni (51.8%, 
comprising 38% of C. jejuni jejuni and 13.8% of C. 
jejuni doylei) and C. coli (13.8%) were the most 
prevalent species. However, 30.9% (n=9) of strains 
had Campylobacter’s characteristics, even if they 
could not be identified using Api Campy 
(bioMérieux SA).  
The results of drug susceptibility tests are reported 
in Table 1. They showed that only gentamicin was 
effective against all strains. Ceftriaxone- and 
amoxicillin-resistant strains represented 34.5% and 
24.1%, respectively. The resistant rate was moderate 
to erythromycin (10.3%) and tetracycline (10.3%), 









TABLE 1: SUSCEPTIBILITY OF CAMPYLOBACTER STRAINS TO ANTIBIOTICS  
 




Ampicillin (AM) 22 (75.9) 7 (24.1) 
Amoxicillin+clavulanic 
acid (AMC) 
28 (96.6) 1 (3.4) 
Ceftriaxone (CRO) 19 (65.5) 10 (34.5) 
Gentamicin (GM) 29 (100) 0 
Erythromycin (E) 26 (89.7) 3 (10.3) 
Tetracycline (TE) 26 (89.7) 3 (10.3) 
Nalidixic acid (NA) 19 (65.9) 10 (34.1) 
Ciprofloxacin (CIP) 25 (86.2) 4 (13.8) 
 
 
Clinical illness of patients infected by 
Campylobacter 
Clinical signs of the patients on presentation were 
as follow: diarrhea (62.1%), abdominal pains 
(62.1%), fever (51.7%), asthenia (44.8%) and 
vomiting (31%) were the most common symptoms. 
A single (3.4%) infected patient had none of these 
signs. Three of 7 (43%) of HIV-positive patients had 
Campylobacter, but only 26 (2%) among the other 
1239 patients.  
 
Epidemiological characteristics of Campylobacter 
enteritis  
The patient variables studied are reported in Table 
2. The number of Campylobacter strains isolated from 
females was more prominent, but the difference was 
not statistically significant (P=0.15; Odds Ratio: 
0.575; 95%CI: 0.26-1.22). No statistically significant 
difference was found between all age ranges of 
Campylobacter infected patients (P=0.14) except those 
of 0-5 and 21-40 years (P=0.62; OR: 0.823; 95%CI: 
0.37-1.79)] which showed a higher infection 
frequency. Attendance at school or not was not a 
risk factor for Campylobacter enteritis (P=0.69; OR: 
1.158; 95%CI: 0.55-2.42); no difference was 
associated with the level of education. All the cases 
of Campylobacter infections were found in patients 
from Ouagadougou. The patients who were in 
touch with pets (3.4%) were more frequently 
infected than those who had no contact (2%) with 
animals (P=0.03; OR: 0.423; 95%CI: 0.19-0.93). 
The frequencies of isolation of Campylobacter were 
more common in January, June, July, October and 
November than other months in 2007 (Figure 2). 
The complete data for the year 2007 did not show 
any statistically significant difference in the monthly 
rates of infection (P=0.20). There was no difference 
between the rates of infection during the dry season 
and the rainy season (P=0.85; OR: 0.930; 95%CI: 
0.42-2.02): indicating that, there was no seasonality 
in the pattern of the disease. 
 
DISCUSSION  
The rate of Campylobacter enteritis in the studied 
population was 2.3%. Such a rate in urban sites of 
Africa is uncommon: the rates reported in most of  
 
other developing countries are usually higher (1, 3, 
19). However, a comparable rate of 2.4% was 
reported in the Northeast of Brazil (21) and in 
Teheran (22). C. jejuni and C. coli were the main 
species identified in Burkina Faso: this result was 
comparable to those found as well in other 
developing countries where enteritis due to 
Campylobacter have been studied as in developed 
countries (1, 3, 5, 6, 19, 23, 24).  
More than 30% of the strains in Burkina Faso were 
not identified by the gallery ApiCampy: this 
limitation has also been reported in was reported by 
other studies using this gallery. The authors 
reported misidentifications of C. concisus for C. 
mucosalis, and they reported additional problems in 
identifying certain C. coli and C. lari strains (4, 25). 
The use of molecular techniques will allow these 
strains to be typed and possibly identify new 
pathogenic species of Campylobacter.  
The infection rate in females was higher than in 
males, although this difference was not statistically 
significant.  In some developed countries, it has 
been demonstrated that the rate of Campylobacter 
enteritis was higher in males than in females (6, 23, 
26). The association between gender and 
campylobacteriosis may vary according to the 
behaviour, geographical area and the population, 
and it can be different within the same country. In 
Burkina Faso, children of 0-5years old and young 
adults of 21-40 years old were the most infected. 
The high recovery rate of Campylobacter species in 
children is common worldwide, and Burkina Faso is 
no exception. However, a high rate in young adults 
comparable to that in children can be associated 
with a common source of contamination: indeed, 
these young adults in Burkina Faso are workers 
who eat in the street, outside of their house. Neither 
schooling, nor the level of education were risk 
factors to enteritis due to Campylobacter, contrary to 
data reported in a study in Jordan where education 
was a risk factor that correlated significantly with 
diarrhea due to Campylobacter enteritis (27). The 
education of the consumers of vector products of 
campylobacteriosis is important in the 
implementation of national programs of 




TABLE 2: SOCIODEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS  
 








Gender       
Male 11 627 638  0.153 0.575 [0.26–1.22] 
Female  18 590 608     
Total 29 1217 1246     
Age (year)       
0-5 12 482 494 0.148   
6-20 1 121 122    
21-40 14 463 477    
41-50 2 75 77    
>50 0 76 76    
Total 29 1217 1246    
Education level       
Not schooled 13 563 576  0.698 1.158 [0.55–2.42] 
All schooled 16 654 670    
Primary school 3  159 162  0.751   
Secondary school 7  262 269     
High school 6  233 239     
Total  29  1217 1246     
Residence in Burkina 
Faso 
      
Ouagadougou 29 1159 1188    
Other localities 0 58 58    
Total 29 1217 1246    
Contact with animal       
Yes 9 255 264 0.034 0.423 [0.19–0.93] 
No 20 962 982    
Total 29 1217 1246    
Hospitalization       
Outpatients  17 623 640 0.28 0.664 [0.31–1.4] 
All inpatients  12 594 606    
Total  29  1217 1246    
HIV infection       
Yes 3  4 7 0.000   
No 26  1213 1239    
Total 29 (2.3) 1217 1246    
Stool consistency       
Formed  0 62 62 0.140   
Pasty  18 792 810    
Liquid 9 226 235    
Mucous  2 137 139    
Total  29 1217 1246    
Leukocytes in stools       
Yes 18 146 164 0.265  1.54 [0.72–3.28] 
No 11 1071 1082    
Total  29 1217 1246    
 
than 95% of the patients came from Ouagadougou 
and the others were also city-dwellers: these 
findings are comparable to those reported by Beatty 
et al., (28) in Kenya. The close proximity to animals 
in developing countries contributes to easy and 




transmitted to humans directly by infected animals 
(1, 3, 4, 5). In Burkina Faso, the results showed that 
contact with live animals was a significant risk 
factor (OR: 0.423; 95%CI: 0.19-0.93; P=0.03). The 
prevalence of HIV infection in Burkina Faso was 
1.6% in 2007, with an estimated number of 130,000 
[110,000-160,000] people of all ages living with HIV 
(29). The diarrheic diseases constitute an important 
part of the opportunist infections in AIDS-patients. 
Statistically significant associations between 
Campylobacter enteritis and AIDS have been 
reported (1, 30). The clinical manifestations and 
substantial mortality are more frequent in AIDS 
patients than HIV-negative patients (1, 24, 31). The 
results obtained in Burkina Faso confirmed these 
observations: HIV-positive patients were more 
infected by Campylobacter than HIV-negative 
patients (P<0.0001). However, Awole et al., (32) 
have reported higher prevalence rates of 
Campylobacter species in HIV-negative patients 
(25%) than in HIV-positive (13.1%). Manfredi et al., 
(33) agree with such a finding in the era of highly 
active antiretroviral therapy (HAART): HIV-
infected persons progressively feel better and 
clinically they look the same as other patients in the 
general population. 
 Numerous works reported that diarrheas due to 
Campylobacter are clinically less severe in the 
developing countries than in the developed 
countries. Watery, mucosal and/or even bloody 
stools associated with fever, abdominal pain, 
vomiting and presence of fecal leukocytes were 
described (1, 3, 5, 21, 22). In Burkina Faso, no bloody 
stools were found and mucosal stools were few (7%) 
in Campylobacter infected patients. The pasty stools 
(62.1%), abdominal pain (62.1%), diarrhea (51.7%), 
fever, asthenia (44.8%) and vomiting (31%) were the 
main clinical signs found in infected patients. The 
presence of leukocytes in 13.2% of stools could be 
associated with Campylobacter, but can also be 
associated with other invasive bacteria often found 
in co-infections. No seasonality was found with 
Campylobacter enteritis in Burkina Faso which is 
similar to reports from several developing countries 
(1, 2, 5); these findings were different from data in 
Ifakara (Tanzania), were Vargas et al., (34) found 
Campylobacter species in 2.5% of children less than 
five years of age, only in the dry season. However, 
the seasonality of campylobacteriosis is much 
debated (10). 
Several studies have reported good correlations 
between disc diffusion and agar dilution methods 
for the drug susceptibility testing of Campylobacter 
in developed and in developing countries (4, 15, 35, 
36). In developing countries, various patterns of 
Campylobacter susceptibility to antibiotics were 
described. The disc diffusion method was used in 
the study in Burkina Faso. The rate of resistance to 
amoxillin (24.1%) was reduced to 
amoxicillin+clavulanic acid (3.4%), while it was 
with ceftriaxone. These antibiotics are commonly 
used against Gram-negative rods in developing 
countries. The amoxicillin and ampicillin activities 
against bacteria are comparable usually. Recent data 
on the resistance of Campylobacter strains isolated 
from humans to amoxicillin are rare.  
The rate of resistance to amoxicillin+clavulanic acid 
in the study in Burkina Faso was lower than that 
(44%) reported by Samie et al., (37) in South Africa. 
However, the resistance rate to ceftriaxon in 
Burkina Faso was higher that (8%) in South Africa 
while it was lower than those reported in other 
cities from developing countries as Ilorin in Nigeria 
(84%) or Teheran in Iran (47%) (23, 38). Gentamicin 
was the sole effective antibiotic against all the 
strains of Campylobacter in Burkina Faso as in Iran 
(38); resistance of 10.2% was reported from north 
India (39), 4 to 21% in Nigeria (23, 37) were found to 
this antibiotic. Erythromycin is widely used in both 
children and adults world wide. It has been 
reported that the resistance rates of Campylobacter to 
erythromycin is increasing and vary between 12 and 
95% (28, 37, 40); however, the rate was lower in 
Burkina Faso (10.3%) and such lower rates were also 
found in north India, (6.1%) and in Sudan (1.7%) 
(15, 39). Besides, Serichantalergs et al., (16) reported 
a decrease in the Campylobacter resistance rates to 
erythromycin, from 1996 to 2000, in urban Bangkok 
(Thailand). None resistant strain was found in 
studies conducted in Kampala (Uganda) and in 
Ilorin (Nigeria) (23, 41). The rate of Campylobacter 
resistance to tetracycline was 10.3%: with this 
antibiotic also various resistance patterns are found 
in developing countries (15, 28, 37, 38, 39). All the 
studies in developing countries report resistant 
Campylobacter to nalidixic acid, at various rates, but 
always higher than those to ciprofloxacin. In a few 
countries, probably in limited populations, 
ciprofloxacin was reported as effective against all 
the strains of Campylobacter (23, 31). The rate may be 
lower than 10% in other developing countries, (41). 
However, the Campylobacter resistance to 
fluoroquinolones is high (11-95%) and continue to 
increase in developing countries, globally, 
particularly in Thailand (16, 28, 37).  
The data reported in Burkina Faso (Table 2) is in 
keeping with this trend. The findings in the study in 
Burkina Faso showed that contact with infected 
animals and HIV infection are significant risk 
factors for acquiring Campylobacter enteritis. No 
seasonality was associated with the disease. The 
strain susceptibility testing to antibiotics showed 
various patterns: gentamicin was effective against 
all the strains, but amoxicillin+clavulanic acid, 
erythromycin and tetracycline showed satisfactory 
activities allowing for their use against 
Campylobacter enteritis in Burkina Faso. The 
implementation of a national program to fight 
against campylobacteriosis will allow for a better 
understanding of the epidemiology of these bacteria 
and to survey the evolution of their resistance to 
antibiotics. The use of molecular techniques will 
enhance the identification and estimation of the 
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